Literature DB >> 2965125

Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.

J A Bowley1, S J Pickering, A J Scantlebury, P Ackrill, D M Jones.   

Abstract

The efficacy of teicoplanin in the treatment of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) was evaluated in a randomised comparison with vancomycin. The dosage regimen used was 50 mg of vancomycin or teicoplanin per 2 1 bag of dialysate for 48 h followed by 25 mg per bag for a further five days. Twelve episodes of peritonitis were studied. There was no significant difference in the bacteriological or clinical cure rates of either antibiotic.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2965125     DOI: 10.1093/jac/21.suppl_a.133

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

Review 1.  Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis.

Authors:  Pasqual Barretti; João Vitor Pereira Doles; Douglas Gonçalves Pinotti; Regina Paolucci El Dib
Journal:  World J Nephrol       Date:  2015-05-06

2.  Teicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosing.

Authors:  D R Guay; W M Awni; C E Halstenson; M T Kenny; W F Keane; G R Matzke
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 3.  Teicoplanin: 10 years of clinical experience.

Authors:  M Trautmann; H Wiedeck; M Ruhnke; M Oethinger; R Marre
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

4.  Efficacy and pharmacokinetics of teicoplanin in hemodialysis patients.

Authors:  B Beckers; H P Brodersen; R M Stolpmann; G Jansen; D Larbig
Journal:  Infection       Date:  1993 Jan-Feb       Impact factor: 3.553

Review 5.  Update on clinical significance of coagulase-negative staphylococci.

Authors:  W E Kloos; T L Bannerman
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

6.  Red man syndrome following intraperitoneal vancomycin in a child with peritonitis.

Authors:  Melissa J Domis; Michael L Moritz
Journal:  Front Pediatr       Date:  2014-06-05       Impact factor: 3.418

Review 7.  Efficacy of antibiotic therapy for peritoneal dialysis-associated peritonitis: a proportional meta-analysis.

Authors:  Pasqual Barretti; João Vitor Pereira Doles; Douglas Gonçalves Pinotti; Regina El Dib
Journal:  BMC Infect Dis       Date:  2014-08-18       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.